Validation of the COVID-19 Fear Scale modified for application during the perinatal period.

IF 2.1 3区医学 Q2 OBSTETRICS & GYNECOLOGY

Journal of Psychosomatic Obstetrics & Gynecology Pub Date : 2022-12-01 DOI:10.1080/0167482X.2022.2050210

Alejandro Irvin Soto Briseño, Rita A Gomez-Diaz, Ricardo Cesar Saldaña Espinoza, Pilar Lavielle, Adriana Leticia Valdez González, Niels H Wacher

{"title":"Validation of the COVID-19 Fear Scale modified for application during the perinatal period.","authors":"Alejandro Irvin Soto Briseño, Rita A Gomez-Diaz, Ricardo Cesar Saldaña Espinoza, Pilar Lavielle, Adriana Leticia Valdez González, Niels H Wacher","doi":"10.1080/0167482X.2022.2050210","DOIUrl":null,"url":null,"abstract":"Purpose: The COVID-19 Fear Scale (FCV-19S) allows screening in general population; however, there is no specific instrument in our population for screening in the perinatal period that considers fear related with COVID-19 and offspring well-being. We aimed to validate the FCV-19S modified for application during the perinatal period.Materials and methods: Analytical, cross-sectional design. After signing consent, women 18-45 years were included. Internal consistency was calculated with Cronbach's alpha, external validity using the Hospital Anxiety and Depression Scale (HADS), factorial analysis and intraclass correlation coefficient for re-test.Results: The sample included 178 women, mean age 31.04 ± 5.9. We obtained internal consistency with Cronbach's alpha = 0.873 (95%CI, 0.842-0.899). Spearman's Rho coefficient was 0.207 (p= .013). All the elements were statistically significant for the polychoric correlation (p<.001). Reliability test-retest with intraclass correlation was 0.873.Conclusions: The version of FCV-19S modified with eight items is a valid measurement instrument for application during the perinatal period, showing adequate internal consistency and external validity with HADS as measure of concurrence to identify anxiety related with COVID-19 during the perinatal period.","PeriodicalId":50072,"journal":{"name":"Journal of Psychosomatic Obstetrics & Gynecology","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosomatic Obstetrics & Gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/0167482X.2022.2050210","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: The COVID-19 Fear Scale (FCV-19S) allows screening in general population; however, there is no specific instrument in our population for screening in the perinatal period that considers fear related with COVID-19 and offspring well-being. We aimed to validate the FCV-19S modified for application during the perinatal period.

Materials and methods: Analytical, cross-sectional design. After signing consent, women 18-45 years were included. Internal consistency was calculated with Cronbach's alpha, external validity using the Hospital Anxiety and Depression Scale (HADS), factorial analysis and intraclass correlation coefficient for re-test.

Results: The sample included 178 women, mean age 31.04 ± 5.9. We obtained internal consistency with Cronbach's alpha = 0.873 (95%CI, 0.842-0.899). Spearman's Rho coefficient was 0.207 (p= .013). All the elements were statistically significant for the polychoric correlation (p<.001). Reliability test-retest with intraclass correlation was 0.873.

Conclusions: The version of FCV-19S modified with eight items is a valid measurement instrument for application during the perinatal period, showing adequate internal consistency and external validity with HADS as measure of concurrence to identify anxiety related with COVID-19 during the perinatal period.

查看原文本刊更多论文

围生期应用修改后的COVID-19恐惧量表的验证

目的:COVID-19恐惧量表(FCV-19S)允许在普通人群中进行筛查;然而，在我们的人群中，没有特定的工具用于围产期筛查，考虑到与COVID-19和后代福祉相关的恐惧。我们的目的是验证改良后的FCV-19S在围产期的应用。材料和方法:分析，横断面设计。在签署同意书后，18-45岁的女性被纳入研究范围。内部一致性采用Cronbach's alpha计算，外部效度采用医院焦虑与抑郁量表(HADS)，因子分析和类内相关系数进行重测。结果:女性178例，平均年龄31.04±5.9岁。Cronbach’s alpha = 0.873 (95%CI, 0.842-0.899)，获得内部一致性。Spearman’s Rho系数为0.207 (p= 0.013)。结论:经8项修改的FCV-19S版本是围产期应用的有效测量工具，与HADS作为识别围产期新冠肺炎相关焦虑的一致性测量指标具有足够的内部一致性和外部效度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Psychosomatic Obstetrics & Gynecology 医学-妇产科学

CiteScore

6.10

自引率

3.20%

发文量

审稿时长

>12 weeks

期刊介绍： The Journal of Psychosomatic Obstetrics and Gynecology was founded in 1982 in order to provide a scientific forum for obstetricians, gynecologists, psychiatrists and psychologists, academic health professionals as well as for all those who are interested in the psychosocial and psychosomatic aspects of women’s health. Another of its aims is to stimulate obstetricians and gynecologists to pay more attention to this very important facet of their profession.